Journal for ImmunoTherapy of Cancer (Nov 2021)

520 Preliminary biomarker and pharmacodynamic (PD) activity of the TGFβ inhibitor SAR439459, alone or in combination with cemiplimab, in a phase 1 clinical study in patients with advanced solid tumors

  • Rui Wang,
  • Ivan Borbath,
  • Patrícia Martin,
  • Armando Santoro,
  • Bernard Doger,
  • Elena Garralda,
  • Oliver Bechter,
  • Giovanni Abbadessa,
  • Debbie Robbrecht,
  • Grob Jean-Jacques,
  • Butler Marcus,
  • Cheng Tina,
  • Bennouna Jaafar,
  • Massimo Di Nicola,
  • Alejo Rodriguez -Vida,
  • Dirk Schadendof,
  • Brigitte Demers,
  • Amele Amrate,
  • Tun Tun Lin,
  • Manisha Brahmachary,
  • Joon Sange Lee,
  • Joachim Theilhaber,
  • Rob Pomponio

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.520
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.